Editorial Policies

Aims and Scope

The journal publishes original papers reporting fundamental, medical experimental and clinical research, literature reviews, lectures, case reports, and information on all relevant issues of clinical pharmacology, medicinal therapy and related subjects.

Topics focused on key issues in basic and clinical pharmacology.

The journal is aimed at researchers, physicians, educators of medical academic institutions, scientists, pharmacologists, druggists  and all specialists in related fields of medicine including residents, research fellows, and medical students.

Our mission:

  1. Integrate Russian scientific efforts and vast experience  in development and use of medicines of various groups with international science and create international space for discussion and opinion sharing scientists in the field of clinical pharmacology and medicinal therapy.
  2. Provide physicians with actual and qualitative scientific information on the most modern and effective medicines.




The rubric publishes review articles, including systematic reviews of research in various areas of the journal and related disciplines, analyzes the literature on a given topic, and summarizes current points of view.
Reviews must comply with international recommendations on systematic literature search methods and standards - the PRISMA standard. Review articles should contain information on methods for searching literature in databases of a multidisciplinary and specialized profile.

Original articles

The section includes:

  • clinical and experimental studies.
  • new theories or ways to solve a problem.

Original research should be designed in accordance with the IMRAD format.

The editorial board strongly recommends observing the following standards for the presentation of their scientific research, depending on its type:

  • parallel group randomized trialsCONSORT standard;
  • observational studies – STROBE standard;
  • clinical trials – SPIRIT standard;
  • diagnostic accuracy studies – STARD standard;
  • clinical case reporting – CARE standard;
  • clinical practice guidelines – AGREE standard;
  • qualitative research – SRQR standard;
  • preclinical animal studies – ARRIVE standard;
  • quality improvement reporting SQUIRE standard;
  • health economic evaluation reporting – CHEERS

All clinical and preclinical studies must be approved by the ethics committee.

All studies involving vulnerable populations should be conducted in accordance with international ethical principles.

The conclusion of the ethics committee is obligatory if any biomaterials were collected.

The editorial board has the right to request from the authors a copy of the conclusion of the ethics committee. Researchers must obtain voluntary informed consent from patients or their legal representatives to participate in the study.

Consent form-must be approved by the ethics committee.

Full information is presented in the Ethical Code of the "Eco-Vector" publishing house.

Lectures for doctors

Articles by professors from major academic and medical centers summarizing current issues of clinical pharmacology and drug therapy.

Clinical pharmacology

Journal accepts reviews and original articles on drug clinical trials.


The review and original articles on the impact farmakologicheski agents depending on the genetic characteristics of individuals are acceptable.


Review and original articles on pharmacological research of plants and preparations from them.

Folk medicine

Review and original articles on research techniques the use of traditional folk medicines.

From the history of medicine

Articles on the history of pharmacology.


Articles about past congresses, scientific conferences and symposiums.


Rules for authors, messages about upcoming training courses, conferences and symposiums.

Discussion to modern points of pharmacology

Experimental Pharmacology

Short communications


Peer Review Process

Content selection

Upon receipt of the manuscript, the executive secretary of the editorial board checks the design of the manuscript.

Authors of manuscripts that do not meet our requirements will receive a template email without detailing the claims. If the manuscript will be received again without appropriate formatting (in accordance with guidelines for authors), it will be rejected.

In case of the appropriate format of a manuscript, the editorial board will make a decision on the compliance of the manuscript with the science profile of the journal.

The accepted manuscript will be sent to the reviewers.


All manuscripts submitted to the Editorial Board of the journal are subject to mandatory double-blind peer review (reviewer does not receive information about the authors of the manuscript, the authors of the manuscript do not receive information about the reviewers).

  1. Review of manuscripts is carried out by members of the Editorial Board and the Editorial Council, as well as by invited reviewers — leading experts in the relevant field. The decision on the choice of a reviewer for the examination of the article is made by the editor-in-chief, Deputy editor-in-chief, Executive Secretary. The review Period is 4 weeks, but at the request of the reviewer it can be extended.
  2. Each reviewer has the right to refuse the review in case of a clear conflict of interest affecting the perception and interpretation of the manuscript. Following the review of the manuscript, the reviewer gives recommendations on the future of the manuscript (each decision of the reviewer must be justified):
  • to accept the manuscript for publication in the present form;
  • to accept the manuscript for publication after correcting the shortcomings noted by the reviewer;
  • to reject the manuscript;
  • to submit the manuscript to the journal of another profile.
  1. The editorial Board of the journal sends the text of reviews to the author. If there are recommendations for revision of the manuscript, the editorial Board proposes to take them into account when preparing a new version of the manuscript.
  2. In case of disagreement with any recommendations (comments) in the response letter to the reviewers, the authors need to clearly argue the reason for the refusal to make the appropriate corrections (additions).
  3. Revision of the article should not take more than two months from the date of sending an electronic message to the authors about the need to make changes. The manuscript modified by the author will be re-sent for review.
  4. The authors make out the answers to the reviewers in separate files and upload them to the site as additional ones on the "summary" tab at the User page. In the case of absence of such a file, further work with the manuscript is suspended, and the authors are notified accordingly.
  5. In case of refusal of the authors to finalize the materials, they must notify the editorial Board in writing of their refusal to publish the article. If the authors do not return the revised version after three months from the date of sending the review, the editorial Board removes it from the account even in the absence of information from the authors with the refusal to finalize the article. In such situations, the authors will be notified of the withdrawal of the manuscript from registration in connection with the expiration of the period allotted for revision.
  6. The editorial Board conducts no more than three rounds of review for each manuscript. If after double revision of the manuscript the reviewers or the editorial Board still have significant comments, the editorial Board rejects the manuscript and removes it from registration. In this case, the authors are notified accordingly.
  7. If the author and reviewers have any unsolvable contradictions regarding the manuscript, the editorial Board has the right to send the manuscript for additional review.
  8. The decision to refuse to publish the manuscript is made at a meeting of the editorial Board in accordance with the recommendations of the reviewers. The message about refusal in the publication goes to the author by e-mail, in the letter reviews and the bases for refusal in the publication are given. The manuscript, not recommended by the decision of the editorial Board for publication, is not accepted for re-consideration.
  9. The presence of a positive review is not a sufficient basis for the publication of the article. The final decision on the publication is made by the editorial Board. In conflict situations, the decision is made by the editor-in-chief.
  10. After the editorial Board of the journal decides on the admission of the manuscript for publication, the editorial Board informs the author and indicates the date of publication.
  11. Originals of reviews are kept in the editorial office for at least 5 years.

Reviews of manuscripts are not published in the public domain and are used only in the internal document circulation of the editorial Board, as well as in communication with the authors.


Publication Frequency

Журнал публикуется ежеквартально (4 выпуска в год). Тираж 700 экземпляров. В выпуске 100-120 стр.

Очередность публикации статей основывается на дате поступления в редакцию наиболее последней дорабтанной версии рукописи, с учетом рекомендаций рецензентов и главного редактора.


Author Self-Archiving

The journal is compliant with Green Open Access mode (formerly known as Open Self-Archiving) for articles distribution.

Terms and definitions

We use the following terms and definitions:

  • Preprint: An early version of an article prior to the version submitted for publication in a journal. Theses and dissertations are considered to be preprints.
  • SMUR (Submitted Manuscript Under Review): The version of the article that is under formal review for inclusion in the journal.
  • AM (Accepted Manuscript): The version of the article that has been accepted for publication. This version may include revisions resulting from peer review but may be subject to further modification by Pharmarus Print Media (for example, copyediting and typesetting).
  • VoR (Version of Record): The version that is formally published. This not includes any Online First article that is formally identified as being published online before the compilation of a journal issue. The VoR includes any post-publication corrections.
  • Personal webpage: Web pages created by you, about you and your research which are hosted on a non-commercial website (such as your institute’s website). Personal profile pages in commercial sharing sites (such as ResearchGate, Academia.edu and Facebook) are not considered to be personal web pages.
  • Department or institutional repository: Web pages hosted by an academic or research institute or department to provide access to the work to promote and the activities of the institute or department, always operating for a non-commercial purpose.
  • Subject repository: Web pages hosted by an organization to provide access to the work from researchers working in a subject or range of subjects, always operating for a non-commercial purpose.
  • Commercial and non-commercial: Commercial means any activity for direct or indirect financial gain. When considering whether a use is commercial or non-commercial, we look at the nature of the activity rather than the nature of the site or organization performing the activity.


What can be self-archived, where, and when



Personal web page

Department or institutional repository

Non-commercial subject repository

(e.g. PubMed Central)

Commercial repository or social media site

(e.g. ResearchGate, Academia.edu, SSRN)

Preprint, SMUR

At any time

At any time

At any time

At any time


On acceptance

On acceptance

On acceptance

Abstract only plus link to VoR on journal site


Abstract only plus link to VoR on journal site

Abstract only plus link to VoR on journal site

Abstract only plus link to VoR on journal site

Abstract only plus link to VoR on journal site


Plan S compliance

Our Green OA policy is not compatible with Plan S, and our License to Publish agreements with authors may conflict with authors' agreements with their cOAlition S funders. Authors should publish as Gold OA to be compliant with Plan S.

Creative Commons and other end-user licenses

Preprints and SMURs can be made publicly accessible under any license terms the authors choose. We recommend a Creative Commons CC-BY or a more restrictive CC license.

Accepted Manuscripts can be made accessible under a Creative Commons CC-BY-NC-ND license or equivalent, but not a more permissive license. We do not allow AMs to be made accessible under a CC-BY license, for example.

Third-party material

Before posting articles online, authors should ensure they have the appropriate permission to include any third-party content. When posting articles under a Creative Commons license, the permission should allow the third-party material to be included either (i) under the Creative Commons license or (ii) clearly indicated as being protected by third party copyright, with a clear notice that it cannot be reused without further permissions clearance from the identified third-party rights holder.

Closed deposits and embargo periods

Articles can be deposited in repositories before publication provided the content is only accessible to repository administration staff. This is sometimes referred to as ‘closed deposit’.

Metadata about the article (for example the article title, abstract, and journal citation) can be made public as soon as the article is published. The full text must not be made public before the embargo ends.

Any applicable embargo period starts from the date the Version of Record is first published online as part of a journal’s issue.

Posting content in repositories

We require repositories to include:

  • If an article has not yet been published, a clear statement that the material has been accepted for publication in a revised form, with a link to the journal’s site
  • For all published articles, a link to the article’s Version of Record in journal site – for example, via a DOI-based link.
  • A clear statement about the license terms under which the posted version of the article is deposited.

Example statements are:

  • This article has been published in a revised form in ………[http://doi.org/XXX]. This version is free to view and download for private research and study only. Not for re-distribution or re-use. © copyright holder.
  • This article has been published in a revised form in ……….[http://doi.org/XXX]. This version is published under a Creative Commons CC-BY-NC-ND. No commercial re-distribution or re-use allowed. Derivative works cannot be distributed. © copyright holder.

Citing content in repositories

When citing an Accepted Manuscript or an earlier version of an article, we request that readers also cite the Version of Record with a DOI link, for example: Subsequently published in revised form in ………[http://doi.org/XXX].


Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 35.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).


Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 5.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).


Editor rejection

Reasons for rejection of manuscripts by the editor without transfer to reviewers:

  • The design of the manuscript does not meet the requirements of the journal;
  • the manuscript does not meet the criteria of any of the journal section;
  • the volume of the manuscript significantly exceeds the maximum allowable one;
  • the materials of the manuscript do not contain illustrative material, statistical analysis of the results obtained, or are presented in an exceptionally concise form, which does not allow assessing the quality of the presented material.


Publishing Ethics

Extract from the Code of Ethics of Eco-Vector LLC (full text)

Publisher and Editorial

 Independently and impartially make decisions about publication:

  • Reject;
  • Resubmit;
  • Accept;

Responsibility and rights of authors

 When submitting a manuscript to a journal, authors should ensure that:

  • all participants who have made a significant contribution to the study are presented as Co-Authors;
  • those who did not participate in the study are not listed as Co-Authors;
  • all Co-authors saw and approved the final version of the work and agreed to submit it for publication (this is confirmed by the signatures of all authors in the cover letter).


The author should not

  1. hide any conflicts of interest that may affect the result and interpretation of the work (*);
  2. publish the submitted manuscript in other publications and hide from the Editorial Office the transfer of the manuscript to another publication (**);
  3. deviate or ignore the Journal's instructions for preparing and sending manuscripts, instructions for working with proofreading instructions regarding deadlines and other instructions of the Editorial Board;
  4. evaluate the work of reviewers.

Violation of the prohibitions will be regarded by the editors as unethical behavior. The manuscript may be rejected by the Editors

In case of violation of paragraph 3, the Publishing House informs the Editor-in-Chief about the unethical behavior of the authors.

The authors adhere to:

  • publication ethics;
  • instructions for submitting a manuscript to the journal;
  • the instructions contained in the letters received and the deadlines indicated in them;
  • instructions for working with proofreading.

The authors have the right to:

  • withdraw the article at any stage of its consideration
  • report the discovery of significant errors in a published article

 Responsibility and rights of Reviewers

The reviewer should not

  • participate in the review of manuscripts in case of conflicts of interest due to competitive, joint and other interactions and relationships with any of the Authors, companies or other organizations associated with the submitted work;
  • use unpublished data obtained from submitted manuscripts in personal research without the written consent of the Author;
  • discuss the manuscript with anyone not authorized to do so by the Editor.

Reviewers should

  • inform the Editor about the discovery of a significant similarity or coincidence between the manuscript in question and any other published work that is within the scientific competence of the Reviewer;
  • keep confidential and not use information or ideas obtained during the review for personal gain.
  • avoid personal criticism of the Author and try to give an objective assessment of the manuscript.


If animals or people were involved in the work as objects of research, the manuscript should indicate that all stages of the study comply with the legislation and regulatory documents of research organizations, and are also approved by the relevant ethical committees.

The authors are obliged to follow ethical principles of conducting medical research involving people, animals, and vulnerable populations.

Patients and respondents participating in a study should be fully informed about the purpose of the study, its results, and the consequences of participating in the study.

 Vulnerable populations include

  • women of reproductive age, minors, elderly and senile patients, people with mental, cognitive and sensory disorders,
  • patients in an emergency, terminally ill or unable to give informed consent,
  • small ethnic groups

 The editors have the right to request

a copy of the opinion of the ethical committee, informed consents, copies of questionnaires, etc.

The editors refer the following to violations of publication ethics:

  • illegal borrowing of text, figures, tables;
  • simultaneous submission of a manuscript to several journals;
  • concealment of a conflict of interest;
  • assessment of the professional qualities of reviewers;
  • illegal co-authorship;
  • multiple publications.

(*) Examples of potential conflicts of interest to be disclosed:

  • receiving financial rewards for participating in a study or writing a manuscript;
  • any connection (contract work, consulting, shareholding, receiving fees, providing expert opinions) with organizations that have a direct interest in the subject of the study or review;
  • patent application or patent registration for research results (copyright, etc.);
  • obtaining financial support for any stage of the research or writing of the manuscript (including grants and other financial support).
  • Information about conflicts of interest received from the authors of the manuscripts should be available only to the editorial board when deciding whether to publish the manuscript. Then information about conflicts of interest should be published as part of the full text of the article.
  • The publisher recommends using the interactive form at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf when writing this part of the manuscript.

(**) The publication of a certain type of article (for example, translated articles) is permitted in some cases, subject to a number of conditions. When submitting a manuscript for secondary publication, the authors must notify the editorial board about this and justify in detail the feasibility of such publication. In the case of a secondary publication, the settlement of issues related to copyright for publication is decided individually in each specific case. The general rules for preparing a manuscript for a "secondary" publication are: indicating a full bibliographic reference to the primary publication, preserving the original bibliography of the primary work.


Attribution of Authorship

Editorial board emphasize that:

Only those persons who have made a significant contribution to the conception of the work, the development, execution, and/or interpretation of the results of the presented study, as well as to the process of writing the manuscript (including scientific and stylistic editing and design in accordance with the requirements of the journal) may be recognized as the Authors of the publication.

When submitting a manuscript to the journal, Authors shall ensure that:

  • All participants who made a significant contribution to the reported study are presented as Co-Authors;
  • Those who did not participate in the study are not listed as Co-Authors;
  • All Co-Authors have read and approved the final version of the paper and agreed to its submission for publication—this shall be confirmed by the signatures of all Authors in the cover letter.

Identification of illegal borrowings is carried out:

  • as part of scientific peer review;
  • through the ANTI-PLAGIARISM system.

At this stage of expertise:

  • The editors do not take into account the percentage of originality calculated by the anti-plagiarism program;
  • The editors relies only on an expert analysis of the full report of the program;
  • The editors allow for complete coincidence in the description of the applied research methods with such in previously published articles, textbooks, manuals.;
  • The editors believe that the introduction, results, discussion and conclusion (conclusions) should be completely original.

If conclusions coincide with those formulated earlier by other researchers, this should be explicitly indicated in the manuscript in the discussion section.


Authors Conflicts of Interest Disclosure form

All Authors must disclose in their manuscript ― declare in the appropriate section of the manuscript ― any financial or other relevant interests that might be construed to influence the findings or interpretation of their research.

Examples of potential conflicts of interest to be disclosed are given below:

  • Receiving financial rewards for participating in the research or writing of a manuscript;
  • Any affiliation (contract work, consulting, equity assets, fees, and expert opinions) with organizations that have a direct interest in the subject matter of the research or review;
  • A patent application or registration for research findings (copyright, etc.);
  • Receiving financial support for any of the stages of conducting the research or writing a manuscript (including grants and other forms of financial support).

Information on conflicts of interest received from the Authors of manuscripts should be available only to the Editorial Board when deciding whether to publish the manuscript. Such information on conflicts of interest shall then be published as part of the full text of the paper.

When writing this part of the manuscript, the Publisher recommends using the interactive form available at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf

A Reviewer shall not participate in the review of manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with any of the Authors, companies, or other organizations related to the submitted paper.

Editors recuse themselves from reviewing manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with Authors, companies, and possibly other organizations related to the manuscript.


Confidentiality and personal data

The Editor and the Editorial Board shall not unnecessarily disclose information on the manuscript under consideration to anyone other than the Authors, Reviewers, possible Reviewers, other Academic Advisors, and the Publisher.

The Editor shall not use unpublished materials disclosed in the submitted manuscript in the Editor’s own research without the written consent of the Author.

Reviewers shall not use unpublished materials from the submitted manuscripts in the Reviewer’s own research without the written consent of the Author.

Reviewers must keep information or ideas obtained during the review process confidential and not use them for personal gain.

Reviewers shall not discuss the manuscript with any person not authorized by the Editor.

Identifiable (personal) information, including patient names and initials or hospital numbers, shall not be published in written descriptions, photographs, and genetic pedigrees unless the information is of great scientific or historical value and the patient (or parent or guardian) gives written consent for its publication.

Ethical guidelines for handling personal data in biomedical research involving human subjects must comply with legal acts, such as the Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines for Health-Related Research Involving Humans (2016)―in particular, Guideline No. 12 “Collection, Storage and Use of Data in Health-Related Research”  ― as well as the Russian Federal Law on Personal Data (No. 152-FZ), implemented on July 27, 2006 .



Retraction’s reasons

The retraction of an already published article is an extreme measure and is applied in the event of the disclosure of facts that were not known during the review.

Reasons for retraction are as follows:

  • detection of incorrect borrowings (plagiarism) in the publication;
  • duplication of the article in several publications;
  • detection of falsifications or fabrications in the work (for example, manipulation of experimental data);
  • detection of serious errors in the work (for example, misinterpretation of the results), which calls into question its scientific value;
  • detection of persons who do not meet the criteria for authorship;
  • a conflict of interest was not announced;
  • article was republished without the consent of the author;
  • the article has not been peer reviewed.

Retraction procedure:

  • Authors, readers, reviewers, editors, and the Publisher can initiate a retraction of a paper by application to the editorial office of the Journal.
  • The Retraction Commission reviews the received application and notifies the interested parties about the beginning of the retraction procedure.
  • The Retraction Commission decides to retract the published paper if there are sufficient facts in favor of retraction.
  • The Retraction Commission notifies the initiator of the retraction of the paper about the results of consideration in written form.
  • If the commission decides to retract the paper, the Journal publishes information that the paper has been retracted, including the metadata of the retracted paper.
  • If papers from the Journal are indexed by any databases, a letter is sent to these databases stating that this paper has been retracted, indicating the reasons for retraction.
  • The editorial board has the right to independently decide on additional sanctions – for example, on the inclusion of authors in the blacklist of the Journal for a certain period, or indefinitely.



The decision of the Editorial Board based on the results of the revision of the primary decision shall be final and not subject to re-appeal.


Publication Frequency

The journal is published quarterly (4 issues per year). Circulation 700 copies. The issue is 100-120 pages.

The order of publication of articles is based on the date of receipt of the most recent revised version of the manuscript, taking into account the recommendations of the reviewers and the editor-in-chief.


Issues upload

Published articles are sent to the Scientific electronic libraries (eLibrary.ru) within three weeks after publication of all language versions at the official journal site. 



The journal is indexed in abstract and full-text databases, scientometric and search systems


Advertising Policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).


  1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
  4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
  • Alcohol
  • Tobacco
  • Weapons, firearms, ammunition
  • Fireworks
  • Gambling and lottery
  • Pornography or related themes
  • Political and religious advertisements
  • Advertisements that claim to have a “miracle” cure or method
  • Advertisements that make unsubstantiated health claims for the products advertised
  • Advertisements directed at children
  1. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  2. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  3. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  4. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  5. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  6. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  7. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  8. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  9. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  10. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  11. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  12. The following online advertising formats are prohibited:
  • Pop-ups and floating advertisements.
  • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
  • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
  • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/



The publisher of the journal provides following open access options to the content of the electronic version of the journal to the following categories:

  • Members of the editorial board - non-expirable;
  • the authors of the published papers - for one year from publication data;
  • Organizations founders of the journal - non-expirable;
  • Organizations to which anniversary thematic issues are dedicated - one-year/

Readers and authors of the journal can connect to the RSS feed to receive up-to-date information about the journal.

As part of scientific and practical events (conferences, symposiums), participants are provided with a free copy of the journal.

The publisher does not send requests to potential authors to submit manuscripts.

The publisher provides an opportunity for reviewers to submit a review to Publons.


Post-publication changes

As part of the policy of post-publishing changes, the following types of articles are published in the journal.


A variety of Erratum. The article does not report errors but clarifies the data of a previously published article.


Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.


Letter to the editor or a reply to the letter.


An article describing the corrections made in an article previously published in the same journal. This type of publication is not a variant of Erratum.


Article in which errors are reported that were made by authors in an earlier publication in the same journal.


Accidental duplication of an article in another Eco-Vector's journal. The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is a duplicate.


Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance t


Article in which errors are reported that were made in an earlier publication in the same journal. Can be Erratum (publishing error) but also Corrigendum (author error).

Expression of Concern

A notification about the integrity of a published article that is typically written by an editor and should be labelled prominently in the item title. It is the responsibility of the editor to initiate appropriate investigative procedures, discover the outcome of the investigation, and notify readers of that outcome in a subsequent published item. The outcome may require the publication of a retraction notice.


Editorial notice of the removal of a previously published article.

The text of the article is removed. The HTML pages and PDF pages of the article are completely removed and replaced by a single page with citation details and an explanation.

Retracted publication

The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is retracted.

Retraction of Publication

Editorial notice of the retraction of a previously published article.


Refutation of an article previously published in the same journal (in a situation where retraction cannot be performed).

For details see Crossmark Policy.


Manuscript submission

If you have read the editorial policy and found that the results of your research correspond to the subject of the journal, you may get to the manuscript submission page.


Accepted manuscripts

The accepted manuscript is submitted to the scientific editor. From this moment on, the authors are strictly prohibited from making any changes to the text of the manuscript without the consent of the scientific editor.

After agreeing on all changes with the scientific editor, the authors will have to upload the final version of the manuscript to their personal account on the website (Word file).

At the next stage, the manuscript will be handed over to the layout editor to create an electronic layout of the article.

This file (proofreading) will be sent to the authors in pdf format for final approval.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies